SUVRETTA CAPITAL MANAGEMENT, LLC Q2 2021 Filing

Filed August 16, 2021

Portfolio Value

$6.7B

Holdings

121

Report Date

Q2 2021

Filing Type

13F-HR

All Holdings (121 positions)

#	Stock	Shares	Value	% Portfolio
101	—CLIMATE CHANGE CRISIS REAL I	200,000	$3.0B	44.93%
102	—OMEGA ALPHA SPAC	300,000	$3.0B	44.64%
103	—HEALTHCOR CATALIO ACQU CORP	300,000	$3.0B	44.20%
104	—EUROPEAN BIOTECH ACQUTN CORP	300,000	$2.9B	43.70%
105	ADAGADAGENE INC	204,000	$2.8B	41.37%
106	—CANO HEALTH INC	674,566	$2.5B	37.21%
107	—DECIBEL THERAPEUTICS INC	263,600	$2.3B	33.91%
108	—BCLS ACQUISITION CORP	200,000	$2.1B	31.50%
109	—TURMERIC ACQUISITION CORP	200,000	$2.0B	29.58%
110	SANASANA BIOTECHNOLOGY INC	100,000	$2.0B	29.40%
111	—FOLEY TRASIMENE ACQUISTN COR	774,375	$1.6B	24.09%
112	—ELLIOTT OPPORTUNITY II CORP	150,000	$1.5B	22.46%
113	—ARYA SCIENCES ACQU CORP IV	100,000	$1.1B	16.03%
114	—EUCRATES BIOMEDICAL ACQU COR	99,999	$984.0M	14.72%
115	FHTXFOGHORN THERAPEUTICS INC	84,000	$896.0M	13.40%
116	—FRAZIER LIFESCIENCES ACQU CO	87,498	$854.0M	12.77%
117	—FINSERV ACQUISITION CORP II	273,149	$328.0M	4.91%
118	—EUROPEAN BIOTECH ACQUTN CORP	100,000	$95.0M	1.42%
119	—TURMERIC ACQUISITION CORP	66,666	$61.0M	0.91%
120	—EUCRATES BIOMEDICAL ACQU COR	33,333	$35.0M	0.52%
121	—FRAZIER LIFESCIENCES ACQU CO	29,166	$32.0M	0.48%

PreviousPage 2 of 2